AzTrials
AzTrials

AnalgesiaNCT06356376

The Effects of Pain and Pain Relief on Peripheral Nerve Excitability

An observational study of Analgesia, run by University of Aarhus at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will assess changes in nerve excitability of C-fibers, and changes in sympathetic or parasympathetic tone, when the subject experiences pain and pain relief. The investigators will continuously measure blood pressure, heart rate, respiration rate, gastric motility, sympathetic skin response and C-fiber… Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Analgesia
What is being tested?
Heat Stimulation
Type of treatment
Medical device
How many people
30 participants
Where
1 siteDenmark
Study dates
20 Dec 2023to 30 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy Subjects

Who may be able to join

  • Healthy Participants able to give informed consent.

Who cannot join

  • Chronic pain conditions
  • Neurological or Psychiatric disease
  • Other major diseases
  • Pain medication within the last 24 hours

Trial locations and contacts

1 site in 1 country.

Alexander G Kristensen, MD, PhD contact

+45 93 52 28 64

alexgramm@clin.au.dk

Denmark1 site, 1 recruiting
  • Danish Pain Research Center

    Aarhus N, 8200

    Alexander G Kristensen, MD,PhD, +45 93 52 28 64, alexgramm@clin.au.dk

    Recruiting

Other trials in Denmark

About this study

This study will assess changes in nerve excitability of C-fibers, and changes in sympathetic or parasympathetic tone, when the subject experiences pain and pain relief.

The investigators will continuously measure blood pressure, heart rate, respiration rate, gastric motility, sympathetic skin response and C-fiber excitability while using thermal stimuli before and after an analgesic.

Conditions
Analgesia
Being tested
Heat Stimulation
Keywords
Pain, Excitability, Microneurography, Autonomic nervous system
Medical subject headings
Agnosia, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Heat StimulationDevice

    Heat stimulation at a painful, but to the subject tolerable level.

Study groups in NCT06356376
Study groupRoleWhat they receive
Healthy ParticipantsNot described
Receives: Device: Heat Stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. C-fiber excitability

    Changes in C-fiber excitability measured in latency changes after electrical stimulation with a paired pulse protocol compared to an unpaired electrical stimulus.

    Measured: Through study completion, an average of 6 months

Secondary outcomes (5)
  1. Action potential duration (ms)

    Averaged analysis from repeated measures of a single nerve fiber signal.

    Measured: Through study completion, an average of 6 months

  2. Action potential amplitude (V)

    Averaged analysis from repeated measures of a single nerve fiber signal.

    Measured: Through study completion, an average of 6 months

  3. Heart-rate variability (ms)

    Comparison of heart-rate variability during experimental pain stimulation and during pain relief.

    Measured: Through study completion, an average of 6 months

  4. Blood pressure variability (mmHg)

    Changes in continuous blood pressure measurement averages during experimental pain stimulation and during pain relief..

    Measured: Through study completion, an average of 6 months

  5. Sympathetic Skin Response (V)

    Amplitude of Sympathetic skin response during pain stimulation and relief respectively.

    Measured: Through study completion, an average of 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2024
  2. Study start20 Dec 2023
  3. Primary completion30 Apr 2024 (estimated)
  4. Study completion30 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06356376
Sponsor's protocol ID
UAarhus_AGK_MNG_2
Status last verified
Dec 2023
First submitted
17 Dec 2023
Last updated
10 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Analgesia, run by University of Aarhus at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alexander G Kristensen, MD, PhD (+45 93 52 28 64, alexgramm@clin.au.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

C-fiber excitability (time frame: Through study completion, an average of 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in